These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23519541)

  • 1. Agomelatine-induced hepatotoxicity.
    Štuhec M
    Wien Klin Wochenschr; 2013 Apr; 125(7-8):225-6. PubMed ID: 23519541
    [No Abstract]   [Full Text] [Related]  

  • 2. Agomelatine in the treatment of mood and anxiety disorders.
    Baldwin DS; Lopes AT
    Br J Hosp Med (Lond); 2010 Mar; 71(3):153-6. PubMed ID: 20220721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Agomelatine: fulminant liver failure in a patient with fatty liver].
    Gruz F; Raffa S; Santucci C; Papale RM; Videla MG; Fernández MG; Yantorno S; Descalzi VI
    Gastroenterol Hepatol; 2014 Feb; 37(2):92-4. PubMed ID: 23849766
    [No Abstract]   [Full Text] [Related]  

  • 4. Focus on agomelatine.
    Green B
    Curr Med Res Opin; 2011 Apr; 27(4):745-9. PubMed ID: 21271795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Early effects of antidepressants].
    Llorca PM
    Encephale; 2012 Dec; 38 Suppl 2():S49-53. PubMed ID: 23279958
    [No Abstract]   [Full Text] [Related]  

  • 6. [Agomelatine in real-life condition: A safe context of prescription? Results of a one-year single-center evaluation].
    Javelot H; Berard M; Grégoire D; Nonnenmacher C
    Therapie; 2018; 73(3):299-301. PubMed ID: 29246378
    [No Abstract]   [Full Text] [Related]  

  • 7. Agomelatine: an agent against anhedonia and abulia?
    Thome J; Foley P
    J Neural Transm (Vienna); 2015 Aug; 122 Suppl 1():S3-7. PubMed ID: 24311062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agomelatine-induced akathisia with concomitant duloxetine medication: a case report.
    Imboden C; Hatzinger M
    Pharmacopsychiatry; 2012 Jun; 45(4):162-3. PubMed ID: 22290205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action.
    Kasper S; Hamon M
    World J Biol Psychiatry; 2009; 10(2):117-26. PubMed ID: 19255935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agomelatine Drug Utilisation Study in Selected European Countries: A Multinational, Observational Study to Assess Effectiveness of Risk-Minimisation Measures.
    Jacquot E; Collin E; Ladner A; Tormos A; Hamm L; Perez-Gutthann S; Gutierrez L; Chirila C; Deltour N
    Pharmaceut Med; 2019 Aug; 33(4):311-319. PubMed ID: 31933191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agomelatine-induced liver injury in a patient with choledocholithiasis.
    Eder P; Permoda-Osip A; Majewski P; Linke K; Rybakowski JK
    Acta Neuropsychiatr; 2015 Feb; 27(1):56-9. PubMed ID: 25335994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agomelatine: to be avoided, with or without a "patient booklet".
    Prescrire Int; 2015 Dec; 24(166):294. PubMed ID: 26788574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tachycardia and precordial pain with agomelatine: a case report].
    Comte H; Auffret M; Lelièvre B; Béné J; Steen P; Gautier S
    Therapie; 2013; 68(5):324-5. PubMed ID: 24225044
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatotoxicity related to agomelatine and other new antidepressants: a case/noncase approach with information from the Portuguese, French, Spanish, and Italian pharmacovigilance systems.
    Montastruc F; Scotto S; Vaz IR; Guerra LN; Escudero A; Sáinz M; Falomir T; Bagheri H; Herdeiro MT; Venegoni M; Montastruc JL; Carvajal A
    J Clin Psychopharmacol; 2014 Jun; 34(3):327-30. PubMed ID: 24561328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin and pro-hypnotic effectiveness of the antidepressant Trazodone: A preliminary evaluation in insomniac mood-disorder patients.
    Giannaccini G; Masala I; Palego L; Betti L; Pacciardi B; Palagini L; Luchini F; Belli S; Lucacchini A; Mauri M
    Clin Biochem; 2016 Oct; 49(15):1152-1158. PubMed ID: 27374436
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug reaction with eosinophilia and systemic symptoms due to agomelatine.
    Kherlopian A; Fischer G; Fong G
    Australas J Dermatol; 2021 May; 62(2):e336-e337. PubMed ID: 33216948
    [No Abstract]   [Full Text] [Related]  

  • 17. Agomelatine as chronopsychopharmaceutics restoring circadian rhythms and enhancing resilience to stress: a wishfull thinking or an innovative strategy for superior management of depression?
    Jakovljević M
    Psychiatr Danub; 2011 Mar; 23(1):2-9. PubMed ID: 21448091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agomelatine may improve REM sleep behavior disorder symptoms.
    Bonakis A; Economou NT; Papageorgiou SG; Vagiakis E; Nanas S; Paparrigopoulos T
    J Clin Psychopharmacol; 2012 Oct; 32(5):732-4. PubMed ID: 22926620
    [No Abstract]   [Full Text] [Related]  

  • 19. Agomelatine: innovation for the benefit of depressed patients.
    Rouillon F
    CNS Drugs; 2009; 23 Suppl 2():1-2. PubMed ID: 19708720
    [No Abstract]   [Full Text] [Related]  

  • 20. [A study of the efficacy and safety of valdoxan in the treatment of a depressive episode].
    Soldatkin VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(9):36-42. PubMed ID: 24107878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.